Search Results - "Gao, Sophie"

Refine Results
  1. 1

    Targeting HDACs for diffuse large B-cell lymphoma therapy by Wu, Chunyan, Song, Qiao, Gao, Sophie, Wu, Shaoling

    Published in Scientific reports (02-01-2024)
    “…Histone deacetylases (HDACs) are involved in tumorigenesis and progression, however, their role in diffuse large B-cell lymphoma (DLBCL) is not well…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison by Mahon, Ronan, Tiwari, Santosh, Koch, Mirja, Ferraris, Matias, Betts, Keith A, Wang, Yan, Gao, Sophie, Proot, Pascal

    “…To compare the efficacy of erenumab versus rimegepant as preventive treatment for patients with episodic and chronic migraine using an anchor-based…”
    Get full text
    Journal Article
  4. 4

    Global Health Values of a Multidirectional Near Peer Training Program in Surgery, Pathology, Anatomy, Research Methodology, and Medical Education for Haitian, Rwandan, and Canadian Medical Students by Elharram, Malik, Dinh, Trish, Lalande, Annie, Ge, Susan, Gao, Sophie, Noël, Geoffroy

    Published in Annals of global health (01-03-2017)
    “…As health care delivery increasingly requires providers to cross international borders, medical students at McGill University, Canada, developed a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US dataset by Waterhouse, David, Lam, Jenny, Betts, Keith A., Yin, Lei, Gao, Sophie, Yuan, Yong, Hartman, John, Rao, Sumati, Lubinga, Solomon, Stenehjem, David

    Published in Data in brief (01-08-2021)
    “…While results from clinical trials are important in determining the efficacy of treatment, restrictive eligibility criteria may limit generalizability to…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Abstract 12315: Healthcare Resource Utilization and Costs Associated With New York Heart Association Functional Class in Patients With Obstructive Hypertrophic Cardiomyopathy in the United States by Wang, Yan, Gao, Weihua, Gao, Sophie, Dubey, Anand, Han, Xu

    Published in Circulation (New York, N.Y.) (07-11-2023)
    “…Abstract only Background: In obstructive hypertrophic cardiomyopathy (HCM), New York Heart Association (NYHA) class has been associated with increased risks of…”
    Get full text
    Journal Article
  10. 10

    Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer by Waterhouse, David, Lam, Jenny, Betts, Keith A., Yin, Lei, Gao, Sophie, Yuan, Yong, Hartman, John, Rao, Sumati, Lubinga, Solomon, Stenehjem, David

    Published in Lung cancer (Amsterdam, Netherlands) (01-06-2021)
    “…•We assessed real-world survival outcomes for 1L I-O in patients with advanced NSCLC.•Survival estimates were generally lower than those reported in pivotal…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer by Betts, Keith A, Gao, Sophie, Ray, Saurabh, Schoenfeld, Adam J

    Published in Future oncology (London, England) (01-04-2024)
    “…Real-world adverse event (AE) data are limited for first-line (1L) treatments in advanced non-small-cell lung cancer (NSCLC). Using Flatiron Health Spotlight…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    60-OR: Implementing a Machine-Learning Model to Predict Risk of Chronic Kidney Disease (CKD) Progression by Tangri, Navdeep, Singh, Rakesh, Betts, Keith A, Du, Yuxian, Gao, Sophie, Katta, Arvind, Farag, Youssef, Fatoba, Samuel T, Liu, Hongjiao, Chen, Jingyi, Ferguson, Thomas, Whitlock, Reid, Leon, Silvia J, Singh, Ajay K

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Introduction & Objective: Early identification of at-risk CKD can facilitate timely interventions and improve patient (pt) outcomes. This study applied a…”
    Get full text
    Journal Article
  19. 19

    Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate Cancer by Narayan, Vivek, Patel, Miraj Y., Teitsson, Siguroli, Rosenblatt, Lisa, Yin, Xin, Pivneva, Irina, Gao, Sophie, Sundar, Manasvi, Betts, Keith A.

    Published in Clinical genitourinary cancer (01-12-2024)
    “…There is limited real-world data regarding subsequent treatment utilization and clinical outcomes following initial androgen receptor pathway inhibitor (ARPI)…”
    Get full text
    Journal Article
  20. 20